Biocon Biologics report explores pathways to increase biosimilar adoption in low- and middle-income countries Read more
Enzene Biosciences raises $50 million to boost manufacturing capabilities and grow in global markets Read more
Lupin and Axantia enter into license-, supply- and technology-sharing agreement for Pegfilgrastim Read more
Growing opportunities in API manufacturing as innovative biologic approvals increase: GlobalData Read more